Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Pneumonia and Respiratory Infections, and Chronic Obstructive Pulmonary Disease (COPD) Research.
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
Neutrophilic inflammation in bronchiectasis
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial
Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)
Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient survey
Maternal and fetal outcomes in multiparous women with Cystic Fibrosis
Respiratory rate-oxygenation index on the 3<sup>rd</sup> day is the best predictor of treatment failure in COVID-19 patients
A perspective on COVID-19 hospitalised patients across Europe: data from the END-COVID CRC
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Walking the path of treatable traits in interstitial lung diseases
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
Integrative microbiomics in bronchiectasis exacerbations
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19